EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Deep learning reveals pathology-confirmed neuroimaging signatures in Alzheimer’s, vascular and Lewy body dementias

Di Wang iD, Nicolas Honnorat, Jon B Toledo iD, Karl Li, Sokratis Charisis iD, Tanweer Rashid, Anoop Benet Nirmala, Sachintha Ransara Brandigampala, Mariam Mojtabai, Sudha Seshadri, Mohamad Habes iD

Brain · 03.06.2025 · 148 (6) · 1963-1977

DOI: 10.1093/brain/awae388 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 09.12.2024. Verfasst von Di Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Neuroimage Analytics Laboratory and Biggs Institute Neuroimaging Core, Glenn Biggs Institute for Neurodegenerative Disorders, University of Texas Hea…. Hauptthemen laut MEDLINE: Lewy Body Disease, Alzheimer Disease, Deep Learning, Dementia, Vascular. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, South Texas Alzheimer's Disease Research Center, William and Ella Owens Medical Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Concurrent neurodegenerative and vascular pathologies pose a diagnostic challenge in the clinical setting, with histopathology remaining the definitive modality for dementia-type diagnosis. To address this clinical challenge, we introduce a neuropathology-based, data-driven, multi-label deep-learning framework to identify and quantify in vivo biomarkers for Alzheimer’s disease (AD), vascular dementia (VD) and Lewy body dementia (LBD) using antemortem T1-weighted MRI scans of 423 demented and 361 control participants from National Alzheimer’s Coordinating Center and Alzheimer’s Disease Neuroimaging Initiative datasets. Based on the best-performing deep-learning model, explainable heat maps were extracted to visualize disease patterns, and the novel Deep Signature of Pathology Atrophy REcognition (DeepSPARE) indices were developed, where a higher DeepSPARE score indicates more brain alterations associated with that specific pathology. A substantial discrepancy in clinical and neuropathological diagnosis was observed in the demented patients: 71% had more than one pathology, but 67% were diagnosed clinically as AD only. Based on these neuropathological diagnoses and leveraging cross-validation principles, the deep-learning model achieved the best performance, with a balanced accuracy of 0.844, 0.839 and 0.623 for AD, VD and LBD, respectively, and was used to generate the explainable deep-learning heat maps and DeepSPARE indices. The explainable deep-learning heat maps revealed distinct neuroimaging brain alteration patterns for each pathology: (i) the AD heat map highlighted bilateral hippocampal regions; (ii) the VD heat map emphasized white matter regions; and (iii) the LBD heat map exposed occipital alterations. The DeepSPARE indices were validated by examining their associations with cognitive testing and neuropathological and neuroimaging measures using linear mixed-effects models. The DeepSPARE-AD index was associated with Mini-Mental State Examination, the Trail Making Test B, memory, hippocampal volume, Braak stages, Consortium to Establish a Registry for Alzheimer's Disease (CERAD) scores and Thal phases [false-discovery rate (FDR)-adjusted P < 0.05]. The DeepSPARE-VD index was associated with white matter hyperintensity volume and cerebral amyloid angiopathy (FDR-adjusted P < 0.001), and the DeepSPARE-LBD index was associated with Lewy body stages (FDR-adjusted P < 0.05). The findings were replicated in an out-of-sample Alzheimer’s Disease Neuroimaging Initiative dataset by testing associations with cognitive, imaging, plasma and CSF measures. CSF and plasma tau phosphorylated at threonine-181 (pTau181) were significantly associated with DeepSPARE-AD in the AD and mild cognitive impairment amyloid-β positive (AD/MCIΑβ+) group (FDR-adjusted P < 0.001), and CSF α-synuclein was associated solely with DeepSPARE-LBD (FDR-adjusted P = 0.036). Overall, these findings demonstrate the advantages of our innovative deep-learning framework in detecting antemortem neuroimaging signatures linked to different pathologies. The newly deep-learning-derived DeepSPARE indices are precise, pathology-sensitive and single-valued non-invasive neuroimaging metrics, bridging the traditional widely available in vivo T1 imaging with histopathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lewy Body DiseaseAlzheimer DiseaseDeep LearningDementia, VascularNeuroimagingBrainHumansAgedMaleFemaleMagnetic Resonance ImagingAged, 80 and over

Stichwörter der Autor:innen

Alzheimer’s diseaseLewy body dementiaMRIdeep learningneuropathologyvascular dementia

Autor:innen und Institutionen

  • Neuroimage Analytics Laboratory and Biggs Institute Neuroimaging Core, Glenn Biggs Institute for Neurodegenerative Disorders, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
  • Nantz National Alzheimer Center, Stanley Appel Department of Neurology, Houston Methodist Hospital, Houston, TX 77030, USA.
  • Biomedical Image Analytics Division, Research Imaging Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

ORCID-Profile: Di Wang, Jon B Toledo, Sokratis Charisis, Mohamad Habes

Förderung

  • NIA NIH HHS
  • South Texas Alzheimer's Disease Research Center
  • William and Ella Owens Medical Research Foundation
  • NIA
  • NHLBI NIH HHS
  • National Institute of Health
  • NIH HHS

Zitieren

APA

Wang, D., Honnorat, N., Toledo, J. B., Li, K., Charisis, S., Rashid, T., Benet Nirmala, A., Brandigampala, S. R., Mojtabai, M., Seshadri, S., & Habes, M. (2025). Deep learning reveals pathology-confirmed neuroimaging signatures in Alzheimer’s, vascular and Lewy body dementias. Brain, 148(6), 1963-1977. https://doi.org/10.1093/brain/awae388

Vancouver

Wang D, Honnorat N, Toledo JB, Li K, Charisis S, Rashid T, et al. Deep learning reveals pathology-confirmed neuroimaging signatures in Alzheimer’s, vascular and Lewy body dementias. Brain. 2025;148(6):1963-1977. doi:10.1093/brain/awae388

BibTeX
@article{Wang2025,
  author = {Wang, Di and Honnorat, Nicolas and Toledo, Jon B and Li, Karl and Charisis, Sokratis and Rashid, Tanweer and Benet Nirmala, Anoop and Brandigampala, Sachintha Ransara and Mojtabai, Mariam and Seshadri, Sudha and Habes, Mohamad},
  title = {Deep learning reveals pathology-confirmed neuroimaging signatures in Alzheimer’s, vascular and Lewy body dementias},
  journal = {Brain},
  year = {2025},
  volume = {148},
  number = {6},
  pages = {1963--1977},
  doi = {10.1093/brain/awae388}
}
Kostenlos starten →